Clinical Trials Logo

Acute Otitis Externa clinical trials

View clinical trials related to Acute Otitis Externa.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03196973 Completed - Clinical trials for Acute Otitis Externa

Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis Externa

Start date: July 22, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if a combination of an antibiotic plus a corticosteroid is safe and effective in treating AOE

NCT ID: NCT02918773 Completed - Acute Otitis Media Clinical Trials

Pediatric Emergency Department Smartphone Otoscope Study (PED-Oto)

Start date: October 15, 2016
Phase: N/A
Study type: Interventional

Acute otitis media (AOM), defined as acute inflammation in the middle ear, is a leading cause of health encounters and antimicrobial prescriptions in children worldwide. Diagnosis of AOM is often dependent on a brief view of the tympanic membrane in an uncooperative child's ear canal. As a consequence, AOM may be inappropriately diagnosed when visualization of the tympanic membrane (ear drum) is not optimal. Improved methods for visualizing the tympanic membrane including capturing still images and recording video of the ear exam would be beneficial in the diagnosis and management of otic complaints, including acute and chronic otitis media. Use of a smartphone otoscope has the potential to optimize clinician ability to manage otic complaints, visualize the tympanic membrane, and support antimicrobial stewardship. This study will be conducted as a randomized control study in two affiliated children's hospital emergency departments. Twenty volunteer clinicians will be randomly assigned to use either a smartphone otoscope or a conventional otoscope for all otic examinations for a 6-month period.

NCT ID: NCT02801370 Completed - Clinical trials for Acute Otitis Externa

Phase 3 Study of OTO-201 in Acute Otitis Externa

Start date: June 2016
Phase: Phase 3
Study type: Interventional

This is a prospective, randomized, double-blind, sham-controlled, multicenter, Phase 3 study in which eligible subjects with acute otitis externa (AOE) will be randomized to receive a single administration of either 12 mg OTO-201 or Sham-Control (empty syringe) to the external auditory canal of the affected ear(s).

NCT ID: NCT02216071 Completed - Clinical trials for Acute Otitis Externa

Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa

Start date: July 20, 2014
Phase: Phase 3
Study type: Interventional

The purpose of the study is to demonstrate the clinical therapeutic non-inferiority of EXL CDOS to commercially available Ciprofloxacin 0.3% and Dexamethasone 0.1% Sterile Otic Suspension (Ciprodex®, Alcon) in the treatment of acute otitis externa (AOE) when administered twice daily for 7 days.

NCT ID: NCT01535599 Completed - Clinical trials for Acute Otitis Externa

Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa

Start date: March 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study was to demonstrate the superiority of AL-60371, 0.3% Otic Suspension relative to AL-60371 Vehicle based on clinical cures at test-of-cure (TOC) for the treatment of acute otitis externa (AOE).

NCT ID: NCT01535560 Completed - Clinical trials for Acute Otitis Externa

Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa

Start date: April 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study was to demonstrate superiority of AL-60371 relative to Vehicle based on clinical cures at test-of-cure (TOC) for the treatment of acute otitis externa (AOE).

NCT ID: NCT01447017 Completed - Clinical trials for Acute Otitis Externa

A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis

Start date: November 2011
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate safety and tolerability of DPK-060 2% ear drops compared to placebo for DPK-060 ear drops in patients with acute external otitis. The secondary objectives are to evaluate clinical cure and microbiological growth following treatment with DPK-060 2% ear drops compared to placebo for DPK-060 ear drops.

NCT ID: NCT00961675 Completed - Clinical trials for Acute Otitis Externa

FST-201 in the Treatment of Acute Otitis Externa

Start date: August 31, 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This study will be conducted at one site, the Lyndon B. Johnson (LBJ) Tropical Medical Center, Department of Otolaryngology, in Pago Pago, American Samoa.

NCT ID: NCT00750633 Completed - Clinical trials for Acute Otitis Externa

A Phase III Study of an Otic Formulation in Acute Otitis Externa

Start date: June 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if an otic formulation is safe and effective for the treatment of acute otitis externa (AOE).